Literature DB >> 23165357

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT).

Alan C Hartford1, James M Galvin, David C Beyer, Thomas J Eichler, Geoffrey S Ibbott, Brian Kavanagh, Christopher J Schultz, Seth A Rosenthal.   

Abstract

Intensity-modulated radiation therapy (IMRT) is a complex technique for the delivery of radiation therapy preferentially to target structures while minimizing doses to adjacent normal critical structures. It is widely utilized in the treatment of a variety of clinical indications in radiation oncology, including tumors of the central nervous system, head and neck, breast, prostate, gastrointestinal tract, and gynecologic organs, as well as in situations where previous radiation therapy has been delivered, and has allowed for significant therapeutic advances in many clinical areas. IMRT treatment planning and delivery is a complex process. Safe and reliable delivery of IMRT requires appropriate process design and adherence to quality assurance (QA) standards. A collaborative effort of the American College of Radiology and American Society for Therapeutic Radiation Oncology has produced a practice guideline for IMRT. The guideline defines the qualifications and responsibilities of all the involved personnel, including the radiation oncologist, physicist, dosimetrist, and radiation therapist. Factors with respect to the QA of the treatment planning system, treatment-planning process, and treatment-delivery process are discussed, as are issues related to the utilization of volumetric modulated arc therapy. Patient-specific QA procedures are presented. Successful IMRT programs involve integration of many processes: patient selection, patient positioning/immobilization, target definition, treatment plan development, and accurate treatment delivery. Appropriate QA procedures, including patient-specific QA procedures, are essential to ensure quality in an IMRT program and to assure patient safety.

Entities:  

Mesh:

Year:  2012        PMID: 23165357     DOI: 10.1097/COC.0b013e31826e0515

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  28 in total

1.  SBRT and extreme hypofractionation: A new era in prostate cancer treatments?

Authors:  Filippo Alongi; Alba Fiorentino; Berardino De Bari
Journal:  Rep Pract Oncol Radiother       Date:  2014-10-22

2.  Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.

Authors:  Alice Y Ho; Ase Ballangrud; Guang Li; Gaorav P Gupta; Beryl McCormick; Richard Gewanter; Daphna Gelblum; Melissa Zinovoy; Boris Mueller; Borys Mychalczak; Pinaki Dutta; Karen Borofsky; Preeti Parhar; Marsha Reyngold; Lior Z Braunstein; Mohit Chawla; Kate Krause; Natasha Freeman; Chun Ting Siu; Zachary Cost; Brittany B Arnold; Zhigang Zhang; Simon N Powell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-30       Impact factor: 7.038

3.  Four-dimensional computed tomography in accelerated partial breast irradiation planning: single series from a phase III trial.

Authors:  Icro Meattini; Livia Marrazzo; Margherita Zani; Fabiola Paiar; Stefania Pallotta; Gabriele Simontacchi; Marta Bucciolini; Lorenzo Livi
Journal:  Radiol Med       Date:  2015-04-24       Impact factor: 3.469

Review 4.  Complexity metrics for IMRT and VMAT plans: a review of current literature and applications.

Authors:  Sophie Chiavassa; Igor Bessieres; Magali Edouard; Michel Mathot; Alexandra Moignier
Journal:  Br J Radiol       Date:  2019-07-24       Impact factor: 3.039

5.  Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation.

Authors:  S Braunstein; C M Glastonbury; J Chen; J M Quivey; S S Yom
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-03       Impact factor: 3.825

6.  [Cosmetic results after adjuvant radiotherapy in breast-conserving surgery for breast cancer. Randomized comparison of simple IMRT and 2D radiotherapy].

Authors:  M-L Sautter-Bihl; F Sedlmayer
Journal:  Strahlenther Onkol       Date:  2014-04       Impact factor: 3.621

7.  Dosimetric verification for intensity-modulated arc therapy plans by use of 2D diode array, radiochromic film and radiosensitive polymer gel.

Authors:  Naoki Hayashi; Ryan L Malmin; Yoichi Watanabe
Journal:  J Radiat Res       Date:  2014-01-20       Impact factor: 2.724

8.  The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.

Authors:  A Gabriella Wernicke; Menachem Z Yondorf; Bhupesh Parashar; Dattatreyudu Nori; K S Clifford Chao; John A Boockvar; Susan Pannullo; Philip Stieg; Theodore H Schwartz
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

9.  Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation.

Authors:  Roberto Orecchia; Damaris Patricia Rojas; Federica Cattani; Rosalinda Ricotti; Luigi Santoro; Anna Morra; Raffaella Cambria; Rosa Luraschi; Samantha Dicuonzo; Sara Ronchi; Alessia Surgo; Veronica Dell' Acqua; Paolo Veronesi; Francesca De Lorenzi; Cristiana Fodor; Maria Cristina Leonardi; Barbara Alicja Jereczek-Fossa
Journal:  Med Oncol       Date:  2018-02-13       Impact factor: 3.064

10.  Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.

Authors:  Alba Fiorentino; Rosario Mazzola; Stefania Naccarato; Niccolò Giaj-Levra; Sergio Fersino; Gianluisa Sicignano; Umberto Tebano; Francesco Ricchetti; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiol Med       Date:  2017-02-21       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.